Cystic Fibrosis. ICD-10
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with cystic fibrosis over 6 years who are able to perform FeNO test.
Exclusion criteria
Exclusion criteria: Patients with cystic fibrosis under 6 years Patients in need of hospitalization Patients who have exacerbation (increased cough, sputum, fever and need to be hospitalized) Patients with underlying diseases such as allergic bronchopulmonary aspergillosis, heart failure, tuberculosis Patients with another acute illness during treatment Patients who are allergic to any component of the compound honey syrup Patients requesting exclusion Patients unable to perform FeNO test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FeNO. Timepoint: At the beginning of the study and 12 weeks after the administration of the compound honey syrup. Method of measurement: FeNO Testing Device.;Body Mass Index. Timepoint: At the beginning of the study and 12 weeks after the administration of the compound honey syrup. Method of measurement: Weight / Squared Height.;Pulmonary Symptoms. Timepoint: At the beginning of the study and 12 weeks after the administration of the compound honey syrup. Method of measurement: CFQ-R questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences